Literature DB >> 7781665

Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenon.

S Singh1, J C De Trafford, P A Baskerville, J F Martin.   

Abstract

The cause of the digital artery spasm seen in Raynaud's phenomenon (RP) is unclear. A dysfunction of endothelium-dependent vasodilation might contribute to the development of this spasm. We studied the digital artery responses to endothelium-dependent and independent vasodilators in eight Raynaud's phenomenon patients and eight sex-matched controls. A sequential series of infusions alternating with physiological saline were administered at a rate of 1 mL min-1 via the radial artery. The infusions contained acetylcholine chloride (ACh) 110 nm mL-1 and 550 nm mL-1, L-arginine 50 mumol mL-1, prostacyclin (PGI2) 2.5 ng mL-1 and glyceryl trinitrate (GTN) 4.5 nm mL-1. Digital artery diameter (DAD) and cutaneous temperature were measured. DAD was measured using a high frequency A-mode ultrasound scanner. There was no significant difference in mean brachial artery pressure, digital cutaneous temperature and DAD between the two groups at the start of the study. Comparing responses in the groups, there was a significantly greater increase in DAD and cutaneous temperature to Ach (endothelium-dependent vasodilator) at both concentrations in controls. A significantly greater increase in DAD was obtained in response to GTN (endothelium-independent vasodilator) in the RP subjects. There was no significant difference in response to L-arginine and PGI2 between the groups. These results suggest that a dysfunction of endothelium-dependent vasodilation is present in RP patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781665     DOI: 10.1111/j.1365-2362.1995.tb01546.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Oral L-arginine can reverse digital necrosis in Raynaud's phenomenon.

Authors:  Christopher M Rembold; Carlos R Ayers
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 2.  Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; S Clark
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

3.  Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud's disease.

Authors:  P J Smith; C J Ferro; D S McQueen; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

Review 4.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 5.  Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.

Authors:  Umberto Campia; Ana Barac
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

6.  Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.

Authors:  Audrey Dooley; K Richard Bruckdorfer; David J Abraham
Journal:  Cardiol Res Pract       Date:  2011-10-31       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.